Liver Disease
Recent stories about liver disease
health innovation
hepion pharmaceuticals
Hepion Pharmaceuticals raises US$88.4M to accelerate drug development
Hepion Pharmaceuticals has announced the closing of the company's latest public offering, which raised gross proceeds of US$88.4 million in less than a week.
Read the story